Axogen, Inc.

AXGN ·Healthcare, Medical Devices, United States

Net Cash Flow Breakdown

FY2025 FY2024

Total Cash from Operations: $47.3M

Line Item	Value	% of Total
Capital Expenditures	$3.7M	7.9%
Other Investing	$1.6M	3.3%
Working Capital	$36.0M	76.1%
Net Cash Flow	$6.0M	12.7%